Skip to content

Opening book details…

Can I read Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3) on EtoBox?

Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3) by Eric L. Simpson; Andreas Wollenberg; Weily Soong; Louise Abildgaard Steffensen; Azra Kurbasic; Shannon Schneider; John Zoidis; Jonathan I. Silverberg is a Medicine article available to read on EtoBox.

What is Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3) about?

Background Tralokinumab, as monotherapy or in combination with topical corticosteroids (TCS), has exhibited marked efficacy through 52 weeks in phase 3 trials of adults with moderate-to-severe atopic dermatitis and additional efficacy in a long-term extension trial. Early changes in patient-reported symptoms have not been communicated. Objective To evaluate early changes in patient-reported outcomes (PROs) across the ECZTRA 1, 2, and 3 tralokinumab trials. Methods Monotherapy data (ECZTRA 1 + 2) was pooled; ECZTRA 3 evaluated tralokinumab plus optional TCS. The PROs were assessed through the trials. Results A total of 1596 and 380 patients were randomized in ECZTRA 1 and 2 and ECZTRA 3, respectively. Baseline demographics and clinical characteristics were similar between groups. Early separation from placebo was observed in percentage improvement in worst average daily pruritus numerical rating score (NRS) (week 1, ECZTRA 1 + 2; week 2, ECZTRA 3) and from day 2 in ECZTRA 1 and 2 daily data. More tralokinumab-treated patients achieved clinically meaningful improvements (≥ 4 points) in NRS by week 2 (ECZTRA 1 + 2) or week 3 (ECZTRA 3) vs placebo. Improvements in eczema-related sleep

Who reads Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3)?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Eric L. Simpson; Andreas Wollenberg; Weily Soong; Louise Abildgaard Steffensen; Azra Kurbasic; Shannon Schneider; John Zoidis; Jonathan I. Silverberg
Publisher
Elsevier BV
Published
2022
Language
EN
Field
Medicine (Health Sciences)

More by Eric L. Simpson; Andreas Wollenberg; Weily Soong; Louise Abildgaard Steffensen; Azra Kurbasic; Shannon Schneider; John Zoidis; Jonathan I. Silverberg

Browse all works by Eric L. Simpson; Andreas Wollenberg; Weily Soong; Louise Abildgaard Steffensen; Azra Kurbasic; Shannon Schneider; John Zoidis; Jonathan I. Silverberg